UNC Primary Care of Cary — Cary, North Carolina

UNC Primary Care of Cary is a clinical research site located in Cary, North Carolina, United States 27511.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

UNC Primary Care of Cary has participated in 1 clinical trials.

Therapeutic areas: Multiple Chronic Conditions.

Sponsors: University of North Carolina, Chapel Hill.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cary

Browse all research sites in North Carolina · View every site in Cary

• Duke University Medical Center
• WakeMed Health & Hospitals
• Waverly Hematology Oncology
• Duke Cancer Center Cary
• GSK Investigational Site
• Pfizer Investigational Site
• PMG Research of Cary
• Research Site
• PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
• UNC Health Cancer Care Cary
• North Carolina Retina Associates
• Accellacare - Cary

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Primary Care of Cary?

UNC Primary Care of Cary has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Primary Care of Cary conducted?

UNC Primary Care of Cary has 1 clinical trials on record. Their work covers Multiple Chronic Conditions.

Is UNC Primary Care of Cary accredited by Crixeo Clinical Trials?

UNC Primary Care of Cary has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC Primary Care of Cary?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.